Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity We are seeking a Principal Product Manager, G&A Data & Intelligence to shape data products and intelligence capabilities that help RevMed transact, close, plan, forecast, govern, and scale with trusted business data. As RevMed scales toward commercialization, this role will focus first on ERP and Finance data products that support launch readiness, revenue operations, inventory visibility, demand planning, financial controls, reporting confidence, and executive decision-making. The ideal candidate brings deep ERP and Finance data experience, preferably with NetSuite or a similar ERP platform. While the role spans multiple G&A domains, the highest priority is ERP and Finance data, followed by People data, Procurement data, and Legal data. Product surfaces may include finance data marts, executive reporting products, revenue and inventory intelligence, demand planning datasets, workforce analytics, spend intelligence, contract lifecycle insights, governed business metrics, and natural language access to priority G&A data.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal